HIV care: a changing health care system

Article Abstract:

Health care reform based on a managed care system will affect people with HIV. In 1994, the Henry J. Kaiser Family Foundation held a forum on AIDS and managed care in the era of health care reform. Experts suggest that health care reform is underway, shaped by market forces. The overriding goal of reform is the provision of efficient, high quality care. To assess the quality of HIV care, professionals must develop new quality indicators and care guidelines. Managed care may benefit HIV-infected people by providing comprehensive and coordinated services. A 'cluster of excellence' model of HIV care may cost-effectively meet the special needs of HIV patients in managed care settings. A risk adjustment program can help spread the health care costs of high-risk patients among the whole population. Managed care plans must address the needs of consumers and support the missions of teaching hospitals.

Health care reform

---

HIV disease and managed care: an overview

Article Abstract:

Managed care is changing the health care delivery system and will impact HIV-infected patients. Managed care plans grew rapidly in the 1980s in response to rising health care costs. Types of managed care programs include preferred provider organizations, health maintenance organizations and point-of-service plans, all of which regulate medical decisionmaking. These plans offer incentives to providers and control the use of health services to promote efficiency and limit costs. This emphasis may discourage the enrollment of high cost patients, such as those infected with HIV. Managed care plans are oriented toward primary care and disease prevention which benefits HIV-infected patients. The availability of comprehensive, coordinated services is particularly important for HIV care. Capitation and administrative bureaucracy may limit patient's access to necessary medical care.

---

Risk behavior for HIV infection in participants in preventive HIV vaccine trials: a cautionary note

Article Abstract:

The article points out that participants in HIV vaccine trials have a tendency to increase their risk behavior such as unprotected anal intercourse, during the testing, regardless of the possibility they may be receiving placebo. The conclusion is that participants need additional counseling on high-risk behavior.

Sexual behavior, Statistical Data Included, Testing, Risk factors, HIV infection, HIV infections, Patients, AIDS vaccines

Similar abstracts:

• Abstracts: CDC starts early warning infection control system. Siege relief. States find needle exchanges effective in HIV prevention
• Abstracts: Comprehensive health care reform and managed competition. The American Health Security Act: a single-payer proposal
• Abstracts: Integrated health care, capitated payment, and quality: the role of regulation. Practice guidelines and malpractice litigation: a two-way street
• Abstracts: More expertise needed in death investigations. 'Decent research and closure' needed on medical marijuana, says head of NIH panel
• Abstracts: Relining, rebasing partial and complete dentures. Making better removable partial dentures. Abnormal occlusal conditions: a forgotten part of dentistry

This website is not affiliated with document authors or copyright owners. This page is provided for informational purposes only. Unintentional errors are possible.